000284771 001__ 284771
000284771 005__ 20240229155056.0
000284771 0247_ $$2doi$$a10.1128/mbio.01784-23
000284771 0247_ $$2pmid$$apmid:37830871
000284771 0247_ $$2ISSN$$a2161-2129
000284771 0247_ $$2ISSN$$a2150-7511
000284771 0247_ $$2altmetric$$aaltmetric:155376679
000284771 037__ $$aDKFZ-2023-02082
000284771 041__ $$aEnglish
000284771 082__ $$a570
000284771 1001_ $$0P:(DE-He78)0179ab69c93d0c5110458003dbc8af0c$$aBaccianti, Francesco$$b0$$eFirst author$$udkfz
000284771 245__ $$aEpstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response.
000284771 260__ $$aWashington, DC$$bAmerican Society for Microbiology$$c2023
000284771 3367_ $$2DRIVER$$aarticle
000284771 3367_ $$2DataCite$$aOutput Types/Journal article
000284771 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1700732488_19796
000284771 3367_ $$2BibTeX$$aARTICLE
000284771 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000284771 3367_ $$00$$2EndNote$$aJournal Article
000284771 500__ $$a#EA:F100#LA:F100# / 2023 Oct 13;14(5):e0178423
000284771 520__ $$aThe Epstein-Barr virus (EBV) efficiently transforms primary B cells. Here, we show that this process starts immediately after cellular exposure to infectious viral particles. Virus binding to B cells led to the activation of intracytoplasmic tyrosine kinases and STAT3. Tegument proteins within the virion in turn activated the p38-MK2 pathway upon cell entry, independently of the viral DNA. Engagement of STAT3 and p38/MK2, two pro-inflammatory pathways, was essential for expression of the key EBV transforming gene EBNA2 but also facilitated IL-6 and TNFα release. However, these pathways simultaneously activated ZFP36L1, a stress response protein that targets transcripts with an AU-rich 3'UTR, to reduce IL-6 and TNFα transcription in infected cells. Expression of viral latent proteins after infection amplified the viral effects on p38 and MK2, but also on ZFP36L1, altogether resulting in a transitory and limited increase in IL-6 and TNFα transcription and release. Thus, EBV virions are not merely vehicles that allow injection of the viral DNA into the nucleus but manipulate cellular pathways to initiate transformation while limiting cytokine release. IMPORTANCE The Epstein-Barr virus efficiently infects and transforms B lymphocytes. During this process, infectious viral particles transport the viral genome to the nucleus of target cells. We show here that these complex viral structures serve additional crucial roles by activating transcription of the transforming genes encoded by the virus. We show that components of the infectious particle sequentially activate proinflammatory B lymphocyte signaling pathways that, in turn, activate viral gene expression but also cause cytokine release. However, virus infection activates expression of ZFP36L1, an RNA-binding stress protein that limits the length and the intensity of the cytokine response. Thus, the infectious particles can activate viral gene expression and initiate cellular transformation at the price of a limited immune response.
000284771 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000284771 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000284771 650_7 $$2Other$$aEpstein-Barr virus
000284771 650_7 $$2Other$$aSTAT3
000284771 650_7 $$2Other$$aZFP36L1
000284771 650_7 $$2Other$$ap38-MK2
000284771 7001_ $$0P:(DE-He78)978843766973c9bea62bdd751f7d4dfb$$aMasson, Charlène$$b1
000284771 7001_ $$0P:(DE-He78)3877ae274d0271d6bf311bb46539f013$$aDelecluse, Susanne$$b2$$udkfz
000284771 7001_ $$0P:(DE-He78)4cbe3abf3c7df5d7fbac1c945e4c2fce$$aLi, Zhe$$b3$$udkfz
000284771 7001_ $$0P:(DE-He78)27152949302e3bd0d681a6f0548912b9$$aPoirey, Remy$$b4$$udkfz
000284771 7001_ $$0P:(DE-He78)25d3c74b949988c637571e696fc04b25$$aDelecluse, Henri-Jacques$$b5$$eLast author$$udkfz
000284771 773__ $$0PERI:(DE-600)2557172-2$$a10.1128/mbio.01784-23$$gp. e01784-23$$n5$$pe0178423$$tmBio$$v14$$x2161-2129$$y2023
000284771 909CO $$ooai:inrepo02.dkfz.de:284771$$pVDB
000284771 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0179ab69c93d0c5110458003dbc8af0c$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000284771 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)978843766973c9bea62bdd751f7d4dfb$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000284771 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3877ae274d0271d6bf311bb46539f013$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000284771 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4cbe3abf3c7df5d7fbac1c945e4c2fce$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000284771 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)27152949302e3bd0d681a6f0548912b9$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000284771 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)25d3c74b949988c637571e696fc04b25$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000284771 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000284771 9141_ $$y2023
000284771 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMBIO : 2022$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-03-14T07:11:37Z
000284771 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-03-14T07:11:37Z
000284771 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-03-14T07:11:37Z
000284771 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-03-14T07:11:37Z
000284771 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bMBIO : 2022$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-08-24
000284771 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-08-24
000284771 9202_ $$0I:(DE-He78)F100-20160331$$kF100$$lF100 Pathologie infektionsbedingter Tumoren$$x0
000284771 9201_ $$0I:(DE-He78)F100-20160331$$kF100$$lF100 Pathologie infektionsbedingter Tumoren$$x0
000284771 9200_ $$0I:(DE-He78)F100-20160331$$kF100$$lF100 Pathologie infektionsbedingter Tumoren$$x0
000284771 980__ $$ajournal
000284771 980__ $$aVDB
000284771 980__ $$aI:(DE-He78)F100-20160331
000284771 980__ $$aUNRESTRICTED